Medpace, Inc.

Medpace Holdings Inc is an equity in the USA market. The price is 326.03 USD currently with a change of 4.94 USD (0.02%) from the previous close.

The latest open price was 319.4 USD and the intraday volume is 378,965. The intraday high is 328.06 USD and the intraday low is 317.79 USD.

The latest trade time is Wednesday, July 2, 17:15:00 PDT.

Medpace, Inc. is a global, full-service clinical contract research organization (CRO) headquartered in Cincinnati, Ohio. Established in 1992, the company specializes in providing comprehensive Phase I-IV clinical development services to the biotechnology, pharmaceutical, and medical device industries.

Medpace's mission is to accelerate the global development of safe and effective medical therapeutics through a high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas, including:

• Oncology
• Cardiology
• Metabolic disease
• Endocrinology
• Central nervous system
• Anti-viral and anti-infective

Full-Service Model and Offerings

Operating under a full-service model, Medpace offers a wide range of integrated services designed to streamline the clinical trial process. These services include:

• Study start-up
• Clinical trial management
• Clinical monitoring
• Clinical packaging and supplies
• Biostatistics and data management
• Medical affairs
• Clinical safety and pharmacovigilance
• Regulatory affairs and medical writing
• Quality assurance
• Technology solutions

This comprehensive approach ensures that clients receive end-to-end support throughout the clinical development lifecycle.

Team Continuity

A distinctive feature of Medpace is its commitment to team continuity. Each clinical trial is managed by a dedicated cross-functional team that remains consistent throughout the project's duration, from early planning through close-out.

This continuity fosters strong team chemistry, minimizes disruptions, and ensures high-quality results across all services.

Company Locations

Medpace's global presence spans 44 countries, with approximately 5,900 employees. The company's headquarters are located at 5375 Medpace Way, Cincinnati, Ohio 45227, USA.

In addition to its headquarters, Medpace operates regional offices in:

• Cincinnati, OH, USA
• Dallas, Texas
• Denver, Colorado
• Mexico City, Mexico
• Japan
• China
• Singapore
• South Korea
• Taiwan
• Australia
• Several European nations

Laboratories and Infrastructure

Medpace's dedication to quality and efficiency is evident in its wholly-owned central laboratories, bioanalytical laboratory, imaging core laboratory, and Phase I unit, all located on its clinical research campus in Cincinnati.

This integrated infrastructure enables the company to provide seamless execution of clinical trials, enhancing productivity and reducing the need for duplicate management oversight.

Experience and Reputation

With over three decades of experience, Medpace has built a reputation for its high-science approach and disciplined operating model.

It is a trusted partner for biopharmaceutical, pharmaceutical, biotechnology, and medical device companies worldwide.